Medicare expands coverage for ALS care, eliminating patient cost-sharing

What it does

This bill expands Medicare coverage for specialized ALS (amyotrophic lateral sclerosis) care services—including physician support, physical therapy, speech pathology, respiratory care, and nursing coordination—starting January 1, 2027. It establishes a single bundled Medicare payment of $800 per visit (adjusted annually for inflation) to qualified ALS care providers, with additional payments for clinical trial participation and new technologies, and requires the Comptroller General to review payment adequacy every three years.

Why we flagged it

The bill's core function is to establish new Medicare coverage and payment for specialized ALS care services. It is a straightforward healthcare access and reimbursement measure, not a tax provision, deregulation, or commemorative act.

What the text implies

• The $800 base payment is fixed for 2027–2028 and then indexed to a newly defined 'ALS services market basket'—a metric that does not yet exist and will be defined by HHS, creating potential for future payment volatility or underfunding if the basket is narrowly constructed.
• The Comptroller General's triennial payment review (every 3 years) may recommend higher payments, but the bill does not mandate adoption—the Secretary retains discretion, potentially creating a gap between recommended and actual payment rates.
• Qualified provider requirements are to be prescribed by regulation 'in consultation with' stakeholders, but the bill does not require formal rulemaking for provider qualification standards, only for the payment adjustment mechanism—leaving room for administrative discretion in defining who qualifies.
• The bill requires no cost-sharing for patients but does not explicitly cap total out-of-pocket costs for non-ALS-related services, meaning patients could still face significant costs for other care.
• Clinical trial participation triggers a payment adjustment, but the bill does not specify the amount or methodology, delegating that entirely to HHS regulation.

Who it affects

ALS patients and their families gain guaranteed Medicare coverage for comprehensive specialized care with no cost-sharing, reducing financial barriers to life-extending treatment. Providers receive improved reimbursement, which should reduce wait times and enable investment in care quality and research—benefits that flow directly to patients.

Who stands to gain

• ALS specialty care clinics and providers
• Durable medical equipment suppliers
• Telehealth platforms serving ALS patients
• Clinical research organizations conducting ALS trials

Named in the bill

Medicare, Social Security Act (Section 1861, 1833, 1834), HHS (Department of Health and Human Services), Comptroller General of the US, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), ICD-10-CM (International Classification of Diseases), American Medical Association Specialty Society Relative Value Scale Update Committee, CMS (Centers for Medicare & Medicaid Services)

Where it stands

1 cosponsor: 1 Democrats.

• Feb 3, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 3, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $60,000 in lobbying spend. A filing names 36 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Lisa Murkowski, the sponsor, reported $364,800 in PAC receipts in the 2026 cycle.

• I Am Als — $30,000 on 1 filing
• The Als Association — $30,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.